Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3GF6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,567
Award facts
- Contract value 100% obligated
- $16,566.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,566.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of February 5, 2026. This non-set-aside award was issued on February 4, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, consistently supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. The parent company Cencora, Inc. holds this expansive IDC to deliver specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems worldwide. This specific delivery order for the diabetes medication Ozempic reflects the company's ongoing role in fulfilling essential pharmaceutical needs for federal military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3GF6?
SPE2DR26F3GF6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F3GF6 worth?
The government has obligated $16,567 on SPE2DR26F3GF6.
Is contract SPE2DR26F3GF6 an order under another contract?
Yes. SPE2DR26F3GF6 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3GF6 competed?
The extent of competition for SPE2DR26F3GF6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award